<div id="readability-page-1"><p><span>Oracle (NYSE:ORCL - Get Free Report)</span> had its price objective upped by Mizuho  from $245.00 to $300.00 in a research report issued to clients and investors on Friday,Benzinga reports. The firm presently has an &#34;outperform&#34; rating on the enterprise software provider's stock. Mizuho's price target would suggest a potential upside of 22.50% from the company's previous close.</p><ul><li>Oracle’s 2025 Rally Is Only Half Over: 5 Reasons Why</li></ul><p>A number of other research analysts have also recently weighed in on the stock. TD Cowen boosted their price objective on shares of Oracle from $275.00 to $325.00 and gave the company a &#34;buy&#34; rating in a research report on Wednesday, August 6th. Cowen  reiterated a &#34;buy&#34; rating on shares of Oracle in a research report on Thursday, June 12th. Raymond James Financial  reiterated a &#34;strong-buy&#34; rating on shares of Oracle in a research report on Wednesday, June 18th. JPMorgan Chase &amp; Co. boosted their price objective on shares of Oracle from $135.00 to $185.00 and gave the company a &#34;neutral&#34; rating in a research report on Thursday, June 12th. Finally, Morgan Stanley  reaffirmed an &#34;overweight&#34; rating on shares of Oracle in a research report on Wednesday, June 18th. Nine analysts have rated the stock with a hold rating, twenty-three have given a buy rating and three have issued  a strong buy rating to the stock. According to MarketBeat.com, Oracle presently has an average rating of &#34;Moderate Buy&#34; and a consensus target price of $227.04.</p><p><b>View Our Latest Stock Analysis on Oracle</b></p><h2>Oracle Price Performance</h2><ul><li>Why Options Traders Are Betting Big on Oracle Stock </li></ul><p>Shares of NYSE:ORCL opened at $244.89 on Friday. The company has a debt-to-equity ratio of 4.07, a quick ratio of 0.75 and a current ratio of 0.75. The firm has a fifty day moving average price of $229.06 and a 200 day moving average price of $179.81. Oracle has a fifty-two week low of $118.86 and a fifty-two week high of $260.87. The firm has a market cap of $687.86 billion, a price-to-earnings ratio of 56.43, a P/E/G ratio of 3.64 and a beta of 1.43. </p><p>Oracle (NYSE:ORCL - Get Free Report) last posted its earnings results on Wednesday, June 11th. The enterprise software provider reported $1.70 EPS for the quarter, beating analysts' consensus estimates of $1.64 by $0.06. The firm had revenue of $15.90 billion during the quarter, compared to the consensus estimate of $15.58 billion. Oracle had a return on equity of 87.34% and a net margin of 21.68%. The company's quarterly revenue was up 11.3% compared to the same quarter last year. During the same period in the prior year, the company earned $1.63 EPS.  As a group, sell-side analysts expect that  Oracle will post 5 earnings per share for the current fiscal year. </p><h2>Insider Transactions at Oracle</h2><ul><li>This Fund Manager Says You Should Get Out of Tesla and Apple—Now</li></ul><p>In other news, EVP Maria Smith sold 10,000 shares of Oracle stock in a transaction on Thursday, July 3rd. The shares were sold at an average price of $232.99, for a total transaction of $2,329,900.00. Following the completion of the sale, the executive vice president directly owned 40,807 shares of the company's stock, valued at approximately $9,507,622.93. The trade was a 19.68% decrease in their position. The transaction was disclosed in a document filed with the Securities &amp; Exchange Commission, which is accessible through the SEC website. Also, Director Rona Alison Fairhead bought 480 shares of the stock in a transaction that occurred on Monday, July 7th. The shares were purchased at an average price of $233.87 per share, with a total value of $112,257.60. Following the purchase, the director owned 22,110 shares of the company's stock, valued at approximately $5,170,865.70. This represents a 2.22% increase in their position. The disclosure for this purchase can be found here. Insiders have sold 444,183 shares of company stock valued at $86,521,198 over the last quarter. Insiders own  42.20% of the company's stock. </p><h2>Institutional Trading of Oracle</h2><p>Institutional investors have recently bought and sold shares of the business. Vanguard Group Inc. increased its position in shares of  Oracle by 2.1% during the second quarter. Vanguard Group Inc. now owns 164,278,874 shares of the enterprise software provider's stock worth $35,916,290,000 after purchasing an additional 3,353,461 shares in the last quarter.  State Street Corp increased its position in  Oracle by 1.7% during the second quarter. State Street Corp now owns 73,459,391 shares of the enterprise software provider's stock worth $16,060,427,000 after buying an additional 1,252,723 shares during the period.  Northern Trust Corp increased its position in  Oracle by 0.6% during the first quarter. Northern Trust Corp now owns 19,741,423 shares of the enterprise software provider's stock worth $2,760,048,000 after buying an additional 120,889 shares during the period.  Norges Bank purchased a new stake in  Oracle in the second quarter valued at approximately $4,275,378,000.  Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in shares of  Oracle by 0.4% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 13,884,524 shares of the enterprise software provider's stock valued at $1,941,195,000 after acquiring an additional 59,164 shares during the period. 42.44% of the stock is owned by hedge funds and other institutional investors. </p><h2>About Oracle</h2> (Get Free Report)<p>Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.</p><h2>Featured Articles</h2><ul><li>Five stocks we like better than Oracle</li><li>How to Effectively Use the MarketBeat Ratings Screener</li><li>3 Long-Term Dividend Buys You Can Get for Under $50</li><li>Where to Find Earnings Call Transcripts</li><li>How AEP Became a Critical AI Infrastructure Play</li><li>Using the MarketBeat Dividend Yield Calculator</li><li>How Did Peter Thiel-Backed Crypto Exchange Bullish's IPO Go?</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU9SQ0w?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="330" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU9SQ0w"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Oracle Right Now?</h2><p>Before you consider Oracle, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oracle wasn't on the list.</p><p>While Oracle currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

ORCL

<p>Mizuho has raised its price target for Oracle (NYSE:ORCL) from $245.00 to $300.00, maintaining an "outperform" rating. This suggests a potential upside of 22.5% from Oracle's previous close. Other analysts have also increased their targets, with TD Cowen setting a target of $325.00 and JPMorgan raising it to $185.00. Currently, Oracle has an average rating of "Moderate Buy" with a consensus target price of $227.04. The company's stock opened at $244.89, with a market cap of $687.86 billion and a P/E ratio of 56.43.</p>

Oracle (NYSE:ORCL) Price Target Raised to $300.00 at Mizuho